British drugs company GW Pharmaceuticals celebrated approval for its cannabinoid-based epilepsy medicine EPIDYOLEX® back in June 2018 in the United States.  Now, EPIDYOLEX has also gained approval...

A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment...

Patients with a rare and debilitating form of epilepsy called Dravet syndrome have experienced a significant reduction in seizures after being treated with cannabis. In some cases, patients' seizures were...